 | • レポートコード：QYR9ST01714 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の網膜薬物及び生物製剤市場について調査・分析し、以下の構成でお届け致します。網膜薬物及び生物製剤の種類別には、加齢黄斑変性、糖尿病性網膜症、眼炎症性疾患（ブドウ膜炎）、黄斑円孔に、用途別には、病院、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別網膜薬物及び生物製剤売上データ ・地域別網膜薬物及び生物製剤市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別網膜薬物及び生物製剤市場規模：加齢黄斑変性、糖尿病性網膜症、眼炎症性疾患（ブドウ膜炎）、黄斑円孔 ・用途別網膜薬物及び生物製剤市場規模：病院、クリニック、その他 ・主要メーカーの企業情報：ALLERGAN、AbbVie、Alimera Sciences、Janssen Biotech、Swedish Orphan Biovitrum、Roche、Bristol-Myers Squibb、Genzyme、Genentech 、OCULAR THERAPEUTIX、Bausch & Lomb、UCBCares ・網膜薬物及び生物製剤の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.The global Retinal Drugs and Biologics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Retinal Drugs and Biologics market based on company, product type, end user and key regions.
This report studies the global market size of Retinal Drugs and Biologics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Retinal Drugs and Biologics in these regions.
This research report categorizes the global Retinal Drugs and Biologics market by top players/brands, region, type and end user. This report also studies the global Retinal Drugs and Biologics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
Market size by Product
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Retinal Drugs and Biologics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Retinal Drugs and Biologics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Retinal Drugs and Biologics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Retinal Drugs and Biologics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Retinal Drugs and Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Retinal Drugs and Biologics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Retinal Drugs and Biologics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Product
1.4.2 Age Related Macular Degeneration
1.4.3 Diabetic Retinopathy
1.4.4 Ocular Inflammatory Disease (Uveitis)
1.4.5 Macular Hole
1.5 Market by End User
1.5.1 Global Retinal Drugs and Biologics Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Retinal Drugs and Biologics Market Size
2.1.1 Global Retinal Drugs and Biologics Revenue 2014-2025
2.1.2 Global Retinal Drugs and Biologics Sales 2014-2025
2.2 Retinal Drugs and Biologics Growth Rate by Regions
2.2.1 Global Retinal Drugs and Biologics Sales by Regions
2.2.2 Global Retinal Drugs and Biologics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Retinal Drugs and Biologics Sales by Manufacturers
3.1.1 Retinal Drugs and Biologics Sales by Manufacturers
3.1.2 Retinal Drugs and Biologics Sales Market Share by Manufacturers
3.1.3 Global Retinal Drugs and Biologics Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Drugs and Biologics Revenue by Manufacturers
3.2.1 Retinal Drugs and Biologics Revenue by Manufacturers (2014-2019)
3.2.2 Retinal Drugs and Biologics Revenue Share by Manufacturers (2014-2019)
3.3 Retinal Drugs and Biologics Price by Manufacturers
3.4 Retinal Drugs and Biologics Manufacturing Base Distribution, Product Types
3.4.1 Retinal Drugs and Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Retinal Drugs and Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Retinal Drugs and Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Retinal Drugs and Biologics Sales by Product
4.2 Global Retinal Drugs and Biologics Revenue by Product
4.3 Retinal Drugs and Biologics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Retinal Drugs and Biologics Breakdown Data by End User
6 North America
6.1 North America Retinal Drugs and Biologics by Countries
6.1.1 North America Retinal Drugs and Biologics Sales by Countries
6.1.2 North America Retinal Drugs and Biologics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Retinal Drugs and Biologics by Product
6.3 North America Retinal Drugs and Biologics by End User
7 Europe
7.1 Europe Retinal Drugs and Biologics by Countries
7.1.1 Europe Retinal Drugs and Biologics Sales by Countries
7.1.2 Europe Retinal Drugs and Biologics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Retinal Drugs and Biologics by Product
7.3 Europe Retinal Drugs and Biologics by End User
8 Asia Pacific
8.1 Asia Pacific Retinal Drugs and Biologics by Countries
8.1.1 Asia Pacific Retinal Drugs and Biologics Sales by Countries
8.1.2 Asia Pacific Retinal Drugs and Biologics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Retinal Drugs and Biologics by Product
8.3 Asia Pacific Retinal Drugs and Biologics by End User
9 Central & South America
9.1 Central & South America Retinal Drugs and Biologics by Countries
9.1.1 Central & South America Retinal Drugs and Biologics Sales by Countries
9.1.2 Central & South America Retinal Drugs and Biologics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Retinal Drugs and Biologics by Product
9.3 Central & South America Retinal Drugs and Biologics by End User
10 Middle East and Africa
10.1 Middle East and Africa Retinal Drugs and Biologics by Countries
10.1.1 Middle East and Africa Retinal Drugs and Biologics Sales by Countries
10.1.2 Middle East and Africa Retinal Drugs and Biologics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Retinal Drugs and Biologics by Product
10.3 Middle East and Africa Retinal Drugs and Biologics by End User
11 Company Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Details
11.1.2 Company Business Overview
11.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
11.1.5 ALLERGAN Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 Company Business Overview
11.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AbbVie Retinal Drugs and Biologics Products Offered
11.2.5 AbbVie Recent Development
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Details
11.3.2 Company Business Overview
11.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Alimera Sciences Retinal Drugs and Biologics Products Offered
11.3.5 Alimera Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Company Business Overview
11.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Janssen Biotech Retinal Drugs and Biologics Products Offered
11.4.5 Janssen Biotech Recent Development
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Details
11.5.2 Company Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Products Offered
11.5.5 Swedish Orphan Biovitrum Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Company Business Overview
11.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Roche Retinal Drugs and Biologics Products Offered
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Company Business Overview
11.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Genzyme
11.8.1 Genzyme Company Details
11.8.2 Company Business Overview
11.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Genzyme Retinal Drugs and Biologics Products Offered
11.8.5 Genzyme Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Company Business Overview
11.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Genentech Retinal Drugs and Biologics Products Offered
11.9.5 Genentech Recent Development
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Details
11.10.2 Company Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Products Offered
11.10.5 OCULAR THERAPEUTIX Recent Development
11.11 Bausch & Lomb
11.12 UCBCares
12 Future Forecast
12.1 Retinal Drugs and Biologics Market Forecast by Regions
12.1.1 Global Retinal Drugs and Biologics Sales Forecast by Regions 2019-2025
12.1.2 Global Retinal Drugs and Biologics Revenue Forecast by Regions 2019-2025
12.2 Retinal Drugs and Biologics Market Forecast by Product
12.2.1 Global Retinal Drugs and Biologics Sales Forecast by Product 2019-2025
12.2.2 Global Retinal Drugs and Biologics Revenue Forecast by Product 2019-2025
12.3 Retinal Drugs and Biologics Market Forecast by End User
12.4 North America Retinal Drugs and Biologics Forecast
12.5 Europe Retinal Drugs and Biologics Forecast
12.6 Asia Pacific Retinal Drugs and Biologics Forecast
12.7 Central & South America Retinal Drugs and Biologics Forecast
12.8 Middle East and Africa Retinal Drugs and Biologics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Retinal Drugs and Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Retinal Drugs and Biologics Product Picture
Table Retinal Drugs and Biologics Market Segments
Table Key Manufacturers Retinal Drugs and Biologics Covered
Table Global Retinal Drugs and Biologics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Retinal Drugs and Biologics Sales Market Share by Product 2014-2025
Figure Age Related Macular Degeneration Product Picture
Table Major Manufacturers of Age Related Macular Degeneration
Figure Diabetic Retinopathy Product Picture
Table Major Manufacturers of Diabetic Retinopathy
Figure Ocular Inflammatory Disease (Uveitis) Product Picture
Table Major Manufacturers of Ocular Inflammatory Disease (Uveitis)
Figure Macular Hole Product Picture
Table Major Manufacturers of Macular Hole
Table Global Retinal Drugs and Biologics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Retinal Drugs and Biologics Report Years Considered
Figure Global Retinal Drugs and Biologics Market Size 2014-2025 (Million US$)
Figure Global Retinal Drugs and Biologics Sales 2014-2025 (K Units)
Table Global Retinal Drugs and Biologics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Retinal Drugs and Biologics Sales by Regions 2014-2019 (K Units)
Table Global Retinal Drugs and Biologics Sales Market Share by Regions 2014-2019
Figure Global Retinal Drugs and Biologics Sales Market Share by Regions 2014-2019
Figure 2018 Global Retinal Drugs and Biologics Sales Market Share by Regions
Table Global Retinal Drugs and Biologics Revenue by Regions 2014-2019 (Million US$)
Table Global Retinal Drugs and Biologics Revenue Market Share by Regions 2014-2019
Figure Global Retinal Drugs and Biologics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Retinal Drugs and Biologics Revenue Market Share by Regions
Table Global Retinal Drugs and Biologics Sales by Manufacturers (2014-2019) (K Units)
Table Global Retinal Drugs and Biologics Sales Share by Manufacturers (2014-2019)
Figure Global Retinal Drugs and Biologics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Retinal Drugs and Biologics Revenue by Manufacturers (2014-2019) (Million USD)
Table Retinal Drugs and Biologics Revenue Share by Manufacturers (2014-2019)
Figure Retinal Drugs and Biologics Value Share by Manufacturers in 2018
Table Key Manufacturers Retinal Drugs and Biologics Price (2014-2019) (USD/Unit)
Table Retinal Drugs and Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Retinal Drugs and Biologics Product Type
Table Date of International Manufacturers Enter into Retinal Drugs and Biologics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table Global Retinal Drugs and Biologics Sales Share by Product (2014-2019)
Figure Global Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure Global Retinal Drugs and Biologics Sales Market Share by Product in 2018
Table Global Retinal Drugs and Biologics Revenue by Product (2014-2019) (Million US$)
Table Global Retinal Drugs and Biologics Revenue Share by Product (2014-2019)
Figure Global Retinal Drugs and Biologics Revenue Market Share by Product (2014-2019)
Figure Global Retinal Drugs and Biologics Revenue Market Share by Product in 2018
Table Retinal Drugs and Biologics Price by Product 2014-2019 (USD/Unit)
Table Global Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table Global Retinal Drugs and Biologics Sales Share by End User (2014-2019)
Figure Global Sales Retinal Drugs and Biologics Market Share by End User (2014-2019)
Figure Global Sales Retinal Drugs and Biologics Market Share by End User in 2018
Figure North America Retinal Drugs and Biologics Sales Growth Rate 2014-2019 (K Units)
Figure North America Retinal Drugs and Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Retinal Drugs and Biologics Sales by Countries (2014-2019) (K Units)
Table North America Retinal Drugs and Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Retinal Drugs and Biologics Sales Market Share by Countries
Table North America Retinal Drugs and Biologics Revenue by Countries (2014-2019) (Million US$)
Table North America Retinal Drugs and Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Retinal Drugs and Biologics Revenue Market Share by Countries
Figure United States Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure United States Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table North America Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure 2018 North America Retinal Drugs and Biologics Market Share by Product
Table North America Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table North America Retinal Drugs and Biologics Sales Market Share by End User (2014-2019)
Figure 2018 North America Retinal Drugs and Biologics Market Share by End User
Figure Europe Retinal Drugs and Biologics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Retinal Drugs and Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Retinal Drugs and Biologics Sales by Countries (2014-2019) (K Units)
Table Europe Retinal Drugs and Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Retinal Drugs and Biologics Sales Market Share by Countries
Table Europe Retinal Drugs and Biologics Revenue by Countries (2014-2019) (Million US$)
Table Europe Retinal Drugs and Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Retinal Drugs and Biologics Revenue Market Share by Countries
Figure Germany Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure France Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure UK Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table Europe Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Retinal Drugs and Biologics Market Share by Product
Table Europe Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table Europe Retinal Drugs and Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Retinal Drugs and Biologics Market Share by End User
Figure Asia Pacific Retinal Drugs and Biologics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Retinal Drugs and Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Retinal Drugs and Biologics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Retinal Drugs and Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Retinal Drugs and Biologics Sales Market Share by Countries
Table Asia Pacific Retinal Drugs and Biologics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Retinal Drugs and Biologics Revenue Market Share by Countries
Figure China Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure China Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure India Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Retinal Drugs and Biologics Market Share by Product
Table Asia Pacific Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Retinal Drugs and Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Retinal Drugs and Biologics Market Share by End User
Figure Central & South America Retinal Drugs and Biologics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Retinal Drugs and Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Retinal Drugs and Biologics Sales by Countries (2014-2019) (K Units)
Table Central & South America Retinal Drugs and Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Retinal Drugs and Biologics Sales Market Share by Countries
Table Central & South America Retinal Drugs and Biologics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Retinal Drugs and Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Retinal Drugs and Biologics Revenue Market Share by Countries
Figure Brazil Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table Central & South America Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Retinal Drugs and Biologics Market Share by Product
Table Central & South America Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table Central & South America Retinal Drugs and Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Retinal Drugs and Biologics Market Share by End User
Figure Middle East and Africa Retinal Drugs and Biologics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Retinal Drugs and Biologics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Retinal Drugs and Biologics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Countries
Table Middle East and Africa Retinal Drugs and Biologics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Retinal Drugs and Biologics Revenue Market Share by Countries
Figure GCC Countries Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Retinal Drugs and Biologics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Retinal Drugs and Biologics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Retinal Drugs and Biologics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Retinal Drugs and Biologics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Retinal Drugs and Biologics Market Share by Product
Table Middle East and Africa Retinal Drugs and Biologics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Retinal Drugs and Biologics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Retinal Drugs and Biologics Market Share by End User
Table ALLERGAN Company Details
Table ALLERGAN Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ALLERGAN Recent Development
Table AbbVie Company Details
Table AbbVie Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Alimera Sciences Company Details
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alimera Sciences Recent Development
Table Janssen Biotech Company Details
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Biotech Recent Development
Table Swedish Orphan Biovitrum Company Details
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Swedish Orphan Biovitrum Recent Development
Table Roche Company Details
Table Roche Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Genzyme Company Details
Table Genzyme Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genzyme Recent Development
Table Genentech Company Details
Table Genentech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Recent Development
Table OCULAR THERAPEUTIX Company Details
Table OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table OCULAR THERAPEUTIX Recent Development
Table Bausch & Lomb Company Details
Table UCBCares Company Details
Table Global Retinal Drugs and Biologics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Retinal Drugs and Biologics Sales Market Share Forecast by Regions 2019-2025
Table Global Retinal Drugs and Biologics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Retinal Drugs and Biologics Revenue Market Share Forecast by Regions 2019-2025
Table Global Retinal Drugs and Biologics Sales Forecast by Product 2019-2025 (K Units)
Table Global Retinal Drugs and Biologics Sales Market Share Forecast by Product 2019-2025
Table Global Retinal Drugs and Biologics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Retinal Drugs and Biologics Revenue Market Share Forecast by Product 2019-2025
Table Global Retinal Drugs and Biologics Sales Forecast by End User 2019-2025 (K Units)
Table Global Retinal Drugs and Biologics Sales Market Share Forecast by End User 2019-2025
Figure North America Retinal Drugs and Biologics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Retinal Drugs and Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Retinal Drugs and Biologics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Retinal Drugs and Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Retinal Drugs and Biologics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Retinal Drugs and Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Retinal Drugs and Biologics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Retinal Drugs and Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Retinal Drugs and Biologics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Retinal Drugs and Biologics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Retinal Drugs and Biologics Value Chain
Table Retinal Drugs and Biologics Customers List
Table Retinal Drugs and Biologics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
黄斑変性症（AMD）及び糖尿病性網膜症（DR）薬の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…- 加齢黄斑変性（AMD）の世界市場：市場規模・現状・予測 Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.In 2018, the global Age Related Macular Degeneration (AMD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAG…
- 加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 加齢性黄斑変性症（AMD）の世界市場：市場規模・現状・予測 Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss,…
- 加齢性黄斑変性症（AMD）の世界市場：市場規模・現状・予測 Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss,…